Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
ASTRO Meeting Highlights
Adding Radiation to Systemic Therapy Improves Survival in Patients with Advanced Hepatocellular Cancer
By
Phoebe Starr
ASTRO Meeting Highlights
,
Hepatocellular Carcinoma
February 2023, Vol 14, No 1
According to findings from a phase 3 trial presented at the American Society for Radiation Oncology Annual Meeting 2022, the addition of stereotactic body radiation therapy (SBRT) to sorafenib (Nexavar) can lengthen overall survival (OS) and delay tumor progression in patients with unresectable advanced hepatocellular cancer (HCC) without compromising quality of life.
Read Article
Shortened Course of Radiotherapy Feasible in Men with High-Risk Prostate Cancer
By
Phoebe Starr
Prostate Cancer
,
ASTRO Meeting Highlights
December 2022, Vol 13, No 6
A shortened course of radiation therapy is safe and effective for men with high-risk prostate cancer, according to the results of the phase 3 Prostate Cancer Study 5 (PCS5) trial. These findings were presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting 2022 by the study’s lead investigator Tamim M. Niazi, MD, Associate Professor, Radiation Oncology, and Radiation Oncologist, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
Read Article
Female Patients Undergoing Cancer Treatment Rarely Asked About Sexual Health
By
Phoebe Starr
ASTRO Meeting Highlights
December 2022, Vol 13, No 6
Results from a new study found that radiation oncologists tend to discuss sexual side effects in women undergoing treatment for cervical cancer far less frequently than they discuss sexual side effects in men undergoing treatment for prostate cancer. These findings were presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting 2022 by the study’s lead investigator Jamie Takayesu, MD, Radiation Oncology Resident, University of Michigan Rogel Cancer Center, Ann Arbor.
Read Article
Molecular Subtypes Predict Response to Radiation in Prostate Cancer
By
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read Article
Radiation Boost Improves Local Control, Spares Salvage Mastectomy in Patients with Ductal Carcinoma in Situ
By
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read Article
Survival Increased with Value-Added Stereotactic Body Radiation Therapy in Patients with Lung Cancer
By
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma